NWBI

Monday 2/3 Insider Buying Report: NWBI, RGLS

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Friday, Northwest Bancshares' Director, Timothy M. Hunter, made a $131,300 purchase of NWBI, buying 10,000 shares at a cost of $13.13 a piece. Investors have the opportunity to pick up NWBI at a price even lower than Hunter did, with shares trading as low as $12.63 at last check today which is 3.8% below Hunter's purchase price. Northwest Bancshares is trading down about 2.7% on the day Monday. Before this latest buy, Hunter made one other buy in the past twelve months, purchasing $113,000 shares at a cost of $11.30 a piece.

And at Regulus Therapeutics, there was insider buying on Thursday, by Chief Executive Officer Joseph P. Hagan who purchased 50,000 shares for a cost of $1.09 each, for a total investment of $54,260. This buy marks the first one filed by Hagan in the past twelve months. Regulus Therapeutics is trading up about 10% on the day Monday.

Monday 2/3 Insider Buying Report: NWBI, RGLSVIDEO: Monday 2/3 Insider Buying Report: NWBI, RGLS

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.